The University of Chicago Header Logo

Connection

Daniel Arber to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Daniel Arber has written about Aged, 80 and over.
Daniel Arber
Connection Strength
1.475
Aged, 80 and over
  1. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Mod Pathol. 2019 09; 32(9):1373-1385.
    View in: PubMed
    Score: 0.069
  2. Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis. Mod Pathol. 2017 03; 30(3):382-392.
    View in: PubMed
    Score: 0.059
  3. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance. Mod Pathol. 2016 09; 29(9):996-1003.
    View in: PubMed
    Score: 0.057
  4. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014 Dec; 142(6):803-8.
    View in: PubMed
    Score: 0.051
  5. Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings. Am J Clin Pathol. 2014 Aug; 142(2):190-5.
    View in: PubMed
    Score: 0.050
  6. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
    View in: PubMed
    Score: 0.050
  7. The prognostic value of CXCR4 in acute myeloid leukemia. Appl Immunohistochem Mol Morphol. 2013 Jan; 21(1):79-84.
    View in: PubMed
    Score: 0.045
  8. DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups. Br J Haematol. 2012 Oct; 159(2):182-90.
    View in: PubMed
    Score: 0.044
  9. Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies. Leukemia. 2011 Sep; 25(9):1439-43.
    View in: PubMed
    Score: 0.040
  10. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood. 2009 Feb 26; 113(9):1906-8.
    View in: PubMed
    Score: 0.034
  11. Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary? Hum Pathol. 2008 Sep; 39(9):1331-40.
    View in: PubMed
    Score: 0.033
  12. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas. Appl Immunohistochem Mol Morphol. 2007 Mar; 15(1):1-7.
    View in: PubMed
    Score: 0.030
  13. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia. Genes Chromosomes Cancer. 2006 Oct; 45(10):918-32.
    View in: PubMed
    Score: 0.029
  14. Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with =5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026 Jan 01; 132(1):e70210.
    View in: PubMed
    Score: 0.028
  15. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005 Dec; 29(12):1549-57.
    View in: PubMed
    Score: 0.027
  16. Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. J Clin Pathol. 2025 Aug 18; 78(9):629-635.
    View in: PubMed
    Score: 0.027
  17. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. J Mol Diagn. 2005 Aug; 7(3):346-51.
    View in: PubMed
    Score: 0.027
  18. A Clinically Applicable Model Using Blood Counts to Support the Diagnosis of Prefibrotic Myelofibrosis Versus Essential Thrombocythemia. Am J Hematol. 2025 Oct; 100(10):1772-1778.
    View in: PubMed
    Score: 0.027
  19. Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations. Blood Adv. 2025 Jul 08; 9(13):3370-3380.
    View in: PubMed
    Score: 0.027
  20. Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System. Am J Hematol. 2025 Sep; 100(9):1566-1576.
    View in: PubMed
    Score: 0.027
  21. Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 07; 15(1):88.
    View in: PubMed
    Score: 0.026
  22. Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases. Am J Hematol. 2025 Jun; 100(6):1010-1018.
    View in: PubMed
    Score: 0.026
  23. TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance. Am J Hematol. 2025 Apr; 100(4):552-560.
    View in: PubMed
    Score: 0.026
  24. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. Am J Clin Pathol. 2024 Sep 03; 162(3):233-242.
    View in: PubMed
    Score: 0.025
  25. Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases. Haematologica. 2024 08 01; 109(8):2525-2532.
    View in: PubMed
    Score: 0.025
  26. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.025
  27. STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica. 2024 06 01; 109(6):1825-1835.
    View in: PubMed
    Score: 0.025
  28. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Mod Pathol. 2021 09; 34(9):1673-1685.
    View in: PubMed
    Score: 0.020
  29. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol. 2021 01; 34(1):20-31.
    View in: PubMed
    Score: 0.019
  30. Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology. 2020 06; 76(7):934-941.
    View in: PubMed
    Score: 0.019
  31. Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. Am J Surg Pathol. 2000 May; 24(5):703-9.
    View in: PubMed
    Score: 0.019
  32. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol. 1999 Apr; 111(4):467-76.
    View in: PubMed
    Score: 0.017
  33. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
    View in: PubMed
    Score: 0.016
  34. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018 05; 31(5):690-704.
    View in: PubMed
    Score: 0.016
  35. Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples. Br J Urol. 1997 Aug; 80(2):281-6.
    View in: PubMed
    Score: 0.015
  36. Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis. Am J Clin Pathol. 2017 Jul 01; 148(1):49-57.
    View in: PubMed
    Score: 0.015
  37. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol. 2017 09; 30(9):1213-1222.
    View in: PubMed
    Score: 0.015
  38. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017 08; 102(8):1352-1360.
    View in: PubMed
    Score: 0.015
  39. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017 Aug; 39(4):375-383.
    View in: PubMed
    Score: 0.015
  40. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol. 1996 Jun; 27(6):590-4.
    View in: PubMed
    Score: 0.014
  41. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016 08; 29(8):854-64.
    View in: PubMed
    Score: 0.014
  42. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified. Hum Pathol. 2016 Feb; 48:9-17.
    View in: PubMed
    Score: 0.014
  43. ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis. Blood. 2015 Nov 12; 126(20):2344-5.
    View in: PubMed
    Score: 0.014
  44. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol. 1995 Oct; 26(10):1093-8.
    View in: PubMed
    Score: 0.014
  45. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry. Am J Clin Pathol. 2015 Apr; 143(4):527-34.
    View in: PubMed
    Score: 0.013
  46. UCL3D3 and UCL4D12 reactivity in small B-cell neoplasms with special emphasis on monocytoid B-cell lymphoma. Hum Pathol. 1994 Oct; 25(10):1084-90.
    View in: PubMed
    Score: 0.013
  47. Reactive lymphoid hyperplasia of the terminal ileum: a benign (lymphoma-like) condition that may harbor aberrant immunohistochemical patterns or clonal immunoglobulin heavy chain gene rearrangements. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):585-92.
    View in: PubMed
    Score: 0.013
  48. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014 Apr 24; 123(17):2645-51.
    View in: PubMed
    Score: 0.012
  49. Non-Hodgkin's lymphoma involving the breast. Am J Surg Pathol. 1994 Mar; 18(3):288-95.
    View in: PubMed
    Score: 0.012
  50. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
    View in: PubMed
    Score: 0.012
  51. Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22). Am J Clin Pathol. 2013 Oct; 140(4):525-35.
    View in: PubMed
    Score: 0.012
  52. The bone marrow agar section: a morphologic and immunohistochemical evaluation. Mod Pathol. 1993 Sep; 6(5):592-8.
    View in: PubMed
    Score: 0.012
  53. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993 Apr; 17(4):392-9.
    View in: PubMed
    Score: 0.011
  54. Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient. Am J Dermatopathol. 2013 Feb; 35(1):11-8.
    View in: PubMed
    Score: 0.011
  55. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2012 Nov; 36(11):1619-28.
    View in: PubMed
    Score: 0.011
  56. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol. 2012 May; 36(5):744-52.
    View in: PubMed
    Score: 0.011
  57. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012 Aug; 25(8):1128-39.
    View in: PubMed
    Score: 0.011
  58. Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. Am J Hematol. 2012 Jan; 87(1):45-50.
    View in: PubMed
    Score: 0.010
  59. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am J Surg Pathol. 2011 Sep; 35(9):1373-80.
    View in: PubMed
    Score: 0.010
  60. The frequency of dual TCR-PCR clonality in granulomatous disorders. J Cutan Pathol. 2011 Sep; 38(9):704-9.
    View in: PubMed
    Score: 0.010
  61. Coexisting follicular and mantle cell lymphoma with each having an in situ component: A novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol. 2010 Apr; 133(4):584-91.
    View in: PubMed
    Score: 0.009
  62. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Leuk Res. 2010 May; 34(5):594-7.
    View in: PubMed
    Score: 0.009
  63. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. 2008 Oct; 30(5):425-30.
    View in: PubMed
    Score: 0.008
  64. Chromosomal aberrations in a case of synchronous extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type and bronchogenic adenocarcinoma. Appl Immunohistochem Mol Morphol. 2008 May; 16(3):296-300.
    View in: PubMed
    Score: 0.008
  65. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol. 2005 Sep 01; 23(25):6163-71.
    View in: PubMed
    Score: 0.007
  66. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001 Nov; 14(11):1147-56.
    View in: PubMed
    Score: 0.005
  67. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood. 2001 Jun 15; 97(12):3713-20.
    View in: PubMed
    Score: 0.005
  68. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001 May; 14(5):465-71.
    View in: PubMed
    Score: 0.005
  69. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol. 1999 Nov; 23(11):1386-92.
    View in: PubMed
    Score: 0.004
  70. Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome. A report of five cases and review of the literature. Am J Clin Pathol. 1999 Mar; 111(3):373-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.